Tslp-Bindende Moleküle, Il-33-Bindende Moleküle und Bispezifische Antigenbindende Moleküle und Verwendungen davon
EP4800031
2. September 2026
Anmelder: Newsoara Biopharmaceutical Technology (Suzhou) Co., Ltd. 🇨🇳
Details
- Veröffentlichungs-Nr.
- EP4800031
- Anmeldetag
- 23. Dezember 2025
- Veröffentlichung
- 2. September 2026
- Rechtsraum
- EP
- IPC
- C07K16/24
Abstract
The present disclosure relates to TSLP-binding molecules, IL-33-binding molecules, and bispecific antigen-binding molecules that simultaneously target TSLP and IL-33. The disclosure also relates to nucleic acid molecules encoding said antigen-binding molecules, expression vectors, host cells, compositions thereof, and their use for treating diseases.
Anmelder
- Firma
- Newsoara Biopharmaceutical Technology (Suzhou) Co., Ltd.
- Land
- 🇨🇳 China